Fragoso, Y. D., Mendes, M. F., Arruda, W. O., Becker, J., Brooks, J. B. B., Carvalho, M. d. J., . . . Satomi, M. Nearly one-half of Brazilian patients with multiple sclerosis using natalizumab are DNA-JC virus positive. Thieme Revinter Publicações.
Chicago Style (17th ed.) CitationFragoso, Yara Dadalti, et al. Nearly One-half of Brazilian Patients with Multiple Sclerosis Using Natalizumab Are DNA-JC Virus Positive. Thieme Revinter Publicações.
MLA (9th ed.) CitationFragoso, Yara Dadalti, et al. Nearly One-half of Brazilian Patients with Multiple Sclerosis Using Natalizumab Are DNA-JC Virus Positive. Thieme Revinter Publicações.
Warning: These citations may not always be 100% accurate.